Non-Invasive - anterior nasal swab specimens; no need to swab deep in the nasal cavity for sample collection
Easy to use - simple 4-step process from sample collection to results
This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or with adult-collected anterior nasal (nares) samples from individuals aged 2 years or older
This test is authorized for individuals with symptoms of COVID-19 within the first 7 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests
Individuals should provide all results obtained with this product to their healthcare provider for public health reporting and to receive appropriate medical care
Positive results indicate the presence of viral antigens, but clinical correlation with past medical history and other diagnostic information is necessary to determine infection status
Positive results do not rule out bacterial infection or co-infection with other viruses and the agent detected may not be the definite cause of disease
All negative results are presumptive and confirmation with a molecular assay, if necessary for patient management, may be performed
Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control measures such as isolating from others and wearing masks; negative result should be considered in the context of an individual’s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19
The Advin COVID-19 Antigen Test @ Home is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigens from SARS-CoV-2
The Advin COVID-19 Antigen Test @Home is For FDA Emergency Use Authorization (EUA) only: https://www.fda.gov/medical-devices/covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2
Positive Percent Agreement (PPA) - 82.5%
Negative Percent Agreement (NPA) - 100%
Regular price
$8.71
Sale price
$8.71
Regular price
Unit price
/per
Free Shipping over $50
Free Returns Within 30 days
Couldn't load pickup availability
More Product Details
Active Ingredient:
Dosage Form:
Container Contents:
Case Pack: 1 /
Advin COVID-19 Antigen Test Kit
Regular price
$8.71
Sale price
$8.71
Regular price
Unit price
/per
Worry-free FSA Shopping
Our team selects the best pre-approved FSA and HSA products. No receipts needed on your end!
Fast Shipping
Orders typically leave our warehouse within 24hrs.
Free Shipping on Orders Over $50
All orders over $50 ship for FREE
Easy Returns + Support
Our world-class support team is here for you.
Recently viewed products
FAQs
How long does it take to process an order?
Orders typically leave our warehouse in under 24hrs.
Is this product FSA Eliglible
Yes, our team hand-picks and verifies every product on our store to ensure it is FSA eligible.
What is your return policy?
We accept returns within 30 days of delivery, provided the items are unused and in their original condition. For detailed instructions, please refer to our return policy or contact our support team.
Non-Invasive - anterior nasal swab specimens; no need to swab deep in the nasal cavity for sample collection
Easy to use - simple 4-step process from sample collection to results
This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or with adult-collected anterior nasal (nares) samples from individuals aged 2 years or older
This test is authorized for individuals with symptoms of COVID-19 within the first 7 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests
Individuals should provide all results obtained with this product to their healthcare provider for public health reporting and to receive appropriate medical care
Positive results indicate the presence of viral antigens, but clinical correlation with past medical history and other diagnostic information is necessary to determine infection status
Positive results do not rule out bacterial infection or co-infection with other viruses and the agent detected may not be the definite cause of disease
All negative results are presumptive and confirmation with a molecular assay, if necessary for patient management, may be performed
Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control measures such as isolating from others and wearing masks; negative result should be considered in the context of an individual’s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19
The Advin COVID-19 Antigen Test @ Home is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigens from SARS-CoV-2
The Advin COVID-19 Antigen Test @Home is For FDA Emergency Use Authorization (EUA) only: https://www.fda.gov/medical-devices/covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2
Non-Invasive - anterior nasal swab specimens; no need to swab deep in the nasal cavity for sample collection
Easy to use - simple 4-step process from sample collection to results
This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or with adult-collected anterior nasal (nares) samples from individuals aged 2 years or older
This test is authorized for individuals with symptoms of COVID-19 within the first 7 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests
Individuals should provide all results obtained with this product to their healthcare provider for public health reporting and to receive appropriate medical care
Positive results indicate the presence of viral antigens, but clinical correlation with past medical history and other diagnostic information is necessary to determine infection status
Positive results do not rule out bacterial infection or co-infection with other viruses and the agent detected may not be the definite cause of disease
All negative results are presumptive and confirmation with a molecular assay, if necessary for patient management, may be performed
Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control measures such as isolating from others and wearing masks; negative result should be considered in the context of an individual’s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19
The Advin COVID-19 Antigen Test @ Home is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigens from SARS-CoV-2
The Advin COVID-19 Antigen Test @Home is For FDA Emergency Use Authorization (EUA) only: https://www.fda.gov/medical-devices/covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2